Existing user? Login

PJ Online | News (13 December 2003)

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7279 p801-807
13 December 2003

News summary

DIARY   Branch meetings   Future Events   Conferences

801 Society petitions Privy Council for new Charter but the controversy continues The Council of the Royal Electronicjuice petitioned the Privy Council last week for a new Royal Charter. However, controversy continues to reign with five Council members and the Save Our Society campaign issuing statements expressing disappointment with aspects of the final draft Charter and the process by which it was produced ...more

801 NICE looking to double guidance produced in 2004 The National Institute for Clinical Excellence is to double the amount of guidance it produces next year, its chairman has said ...more

802 Pharmacists put at the centre of plans to increase patient choice in the NHS Pharmacists will play a key role in the Department of Health's plans to expand patient choice within the National Health Service in England ...more

802 Two of six NHS electronic records contracts awarded National telecommunications provider BT has been awarded a 10-year, £620m contract to set up and run the National Health Service Care Records Service for England ...more

803 Antidepressant warning extended to other SSRIs A government warning not to use paroxetine or venlafaxine (Efexor) to treat depression in children has been extended to include sertraline (Lustral), citalopram (Cipramil), escitalopram (Cipralex) and fluvoxamine. The only selective serotonin reuptake inhibitor not to be included in the warning is fluoxetine ...more

803 CSM adviser stands down over latest HRT warnings An adviser to the Committee on Safety of Medicines has stood down from his position on an expert working group following the committee's latest recommendations on hormone replacement therapy (HRT) ...more

803 Improving prescribing practice needs culture change The benefits of pharmacist and nurse prescribing will be limited unless changes are made to the structure and culture of the health service, according to Professor Sir Michael Rawlins, chairman of the National Institute for Clinical Excellence ...more

803 GPs cannot use adrenaline devices Most patients with a diagnosis of anaphylaxis do not know how and when to use auto-injecting adrenaline, and neither do their general practitioners ...more

803 Herbal creams contain steroids Many herbal creams reported as being effective for the treatment of childhood eczema contain corticosteroids, a new study indicates ...more

804 Pharmacists could have greater input in managing patients with dyspepsia Pharmacists could become more involved in the management of patients with dyspepsia when new National Institute for Clinical Excellence guidelines are released, according to Dr Richard Stevens, chairman of the Primary Care Society for Gastroenterology ...more

804 Wales explores central purchasing Central purchasing of medicines for use in primary care in Wales is to be investigated to see whether a workable system can be developed ...more

804 MeReC looks at angiotensin drugs Evidence to support the combined use of an angiotensin converting enzyme inhibitor and an angiotensin II receptor antagonist in hypertension, renal disease and heart failure is, as yet, unconvincing ...more

804 Co-ordinate diabetes services Pharmacy diabetes services in Wales should be better quality controlled, according to the Audit Commission's recent review into diabetes services in Wales ...more

804 Equal benefit for antihypertensives Patients with coronary artery disease who need treatment for high blood pressure gain similar benefits whether their treatment regimen is based on a calcium channel blocker or on a beta blocker, study data indicate ...more

805 Refit boosts business for UniChem award winner A total refit of Medicine Box Chemist, Leicester, and the provision of an extended range of services has led to Unnat Patel being named overall winner of the UniChem Great Business awards for 2003 ...more

805 AAH and East Anglian call off merger deal AAH Pharmaceuticals and East Anglian Pharmaceuticals have cancelled their proposed merger ...more

805 Derby awards its first DPharm degree Mojgan Sani has been awarded a doctor of practice in pharmacy (DPharm) degree by the University of Derby, the first time such a degree has been awarded in the United Kingdom ...more

805 Two developments widen availability of oseltamivir for 'flu Two moves have been made to make oseltamivir (Tamiflu) more available for the treatment and prophylaxis of influenza ...more

Research & Development

AHA conference

806 Ximelagatran is effective alternative to warfarin A new oral anti-clotting drug, ximelagatran (Exanta), is an effective alternative to warfarin for preventing stroke in patients with atrial fibrillation, researchers say ...more

806 New agent provides novel approach for heart failure therapy Tolvaptan, an oral vasopressin-2 antagonist, may provide a new approach to treating heart failure ...more

806 Pexelizumab for heart surgery Pexelizumab, an antibody fragment that inhibits complement activity, might be useful in coronary artery bypass graft (CABG) surgery, research shows ...more

806 Use of cariporide post-surgery Cariporide, a sodium/hydrogen exchange inhibitor, might reduce the risk of myocardial infarction in patients undergoing coronary artery bypass graft surgery ...more

Other R & D news

806 New anaemia drug shows promise A new anaemia drug, CERA (continuous erythropoiesis receptor activator), shows sustained stimulation of red blood cell formation when given once every three weeks, to kidney dialysis patients with chronic renal anaemia ...more

806 New anxiolytics from quinolones? Patients taking fluoroquinolone antibiotics exhibit a low incidence of convulsions and anxiety, probably via GABA antagonism at the brain GABA receptor complex ...more

807 GSK R&D pipeline has 147 projects GlaxoSmithKline unveiled compounds in its research and development pipeline to investors last week, revealing 147 projects, including 82 new chemical entities ...more

807 Italian gene discovery leads to atherosclerosis treatment trial The identification of a genetic mutation in some Italian villagers has led to the first clinical trial of an agent to reduce atherosclerosis in acute coronary syndromes ...more

807 New psoriasis treatment expected Efalizumab, a humanised therapeutic antibody, has shown promise as a treatment for moderate to severe psoriasis ...more

807 Painfree microneedles Researchers have developed microneedles, measuring from 1 to 1,000 microns, small enough to avoid significantly stimulating nerve endings when penetrating the skin ...more

807 New prostate agents A potential new agent for benign prostatic hyperplasia has been developed by a team at University College London ...more

807 Ebola vaccine hope Researchers have successfully immunised mice against the deadly Ebola virus in the hope of developing a human vaccine ...more

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us


Citation: Electronicjuice URI: 20010844

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

У нашей фирмы нужный web-сайт про направление станозолол соло